SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 546 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,610 | -41.9% | 1,186 | -47.3% | 0.02% | +26.3% |
| Q2 2023 | $433,420 | +73.8% | 2,252 | +82.8% | 0.02% | -17.4% |
| Q1 2023 | $249,443 | -24.9% | 1,232 | -34.5% | 0.02% | -28.1% |
| Q2 2022 | $332,000 | +45.0% | 1,880 | +18.2% | 0.03% | +52.4% |
| Q1 2022 | $229,000 | -4.2% | 1,591 | +2.9% | 0.02% | -4.5% |
| Q4 2021 | $239,000 | – | 1,546 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |